An efficient synthesis of 6-substituted aminohexahydro-1H-1,4-diazepines from 2-substituted aminopropenals

Chemical and Pharmaceutical Bulletin

Volumn 44, Issue 12, 1996, Pages 2205-2212

  Harada, Hiroshi ^a   Morie, Toshiya ^a   Hirokawa, Yoshimi ^a   Kato, Shiro ^a  

^a DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

Author keywords

2 substituted aminopropenal; Hexahydro 1H 1,4 diazepine; Serotonin 3 (5 HT3) receptor antagonist; Swern oxidation

Indexed keywords

DIAZEPINE DERIVATIVE; GRANISETRON; HEXAHYDRO 1H 1,4 DIAZEPINE DERIVATIVE; ONDANSETRON; SEROTONIN 3 ANTAGONIST; UNCLASSIFIED DRUG;

ARTICLE; CANCER CHEMOTHERAPY; DRUG OXIDATION; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG STRUCTURE; DRUG SYNTHESIS; VOMITING;

EID: 0030447297     PISSN: 00092363     EISSN: None     Source Type: Journal    
DOI: 10.1248/cpb.44.2205     Document Type: Article

References (45)

1. a) Peroutka S. J., Annu. Rev. Neurosci., 11, 45-60 (1988);
2. b) King F. D., "5-Hydroxytryptamine-3 Receptor Antagonists," ed. by King F. D., Jones B. J., Sanger G. J. CRC Press, Inc., Boca Raton, 1994, pp. 1-43.
3. a) Leibundgut U., Lancranjan I., Lancet, i, 1198 (1987);
4. b) Cunningham D., Pople A., Ford H. T., Hawthorn J., Gazet J. C., Challoner T., ibid., 1, 1461-1462 (1987);
5. c) Andrew P. L. R., Rapeport W. G., Sanger G. J., Trends Pharmacol. Sci., 9, 334-341 (1988).
6. a) Jones B. J., Costall B., Domeney A. M., Kelly M. E., Naylor R. J., Oakley N. R., Tyers M. B., Br. J. Pharmacol., 93, 985-993 (1988);
7. b) Costall B., Naylor R. J., Tyers M. B., Pharmacol. Ther., 47, 181-202 (1990).
8. Loisy C., Beorchia S., Centonze V., Fozard J. R., Shechter P. J., Tell G. P., Cephalalgia, 5, 79-82 (1985).
9. a) Costall B., Domeney A. M., Kelly M. E., Naylor R. J., Tyers M. B., Br. J. Pharmacol. (Proc. Suppl), 90, 89P (1987);
10. b) Costall B., Domeney A. M., Naylor R. J., Tyers M. B., ibid., 92, 881-894 (1987).
11. a) Steadman C. J., Talley N. J., Phillips S. F., Mulvihill C., Gastroenterology, 98, A394 (1990);
12. b) Maxton D. G., Haigh C. G., Whorwell P. J., ibid., 100, A468 (1991);
13. c) Prior A., Read N. W., Gut, 31, A1174 (1990);
14. d) Miyata K., Kamato T., Nishida A., Ito H., Yuki H., Yamano M., Tsutsumi R., Katsuyama Y., Honda K., J. Pharmacol. Exp. Ther., 261, 297-303 (1992).
15. a) Harada H., Morie T., Hirokawa Y., Yoshida N., Kato S., Chem. Pharm. Bull., 43, 1364-1378 (1995);
16. b) Harada H., Morie T., Hirokawa Y., Terauchi H., Fujiwara I., Yoshida N., Kato S., ibid., 43, 1912-1930 (1995).
17. Kato S., Harada H., Morie T., J. Heterocycl. Chem., 32, 637-642 (1995).
18. Harada H., Hirokawa Y., Morie T., Kato S., Heterocycles, 41, 363-371 (1995).
19. Tanaka H., Murakami Y., Torii S., Bull. Chem. Soc. Jpn., 62, 4061-4062 (1989).
20. Arnold L. D., Kalantar T. H., Vederas J. C., J. Am. Chem. Soc., 107, 7105-7109 (1985).
21. a) Mancuso A. J., Huang S.-L., Swern D., J. Org. Chem., 43, 2480-2487 (1978);
22. b) Mancuso A. J., Swern D., Synthesis, 1981, 165-185.
23. Arnold Z., Sauliová J., Krchnák V., Collect. Czech. Chem. Commun., 38, 2633-2640 (1973).
24. The oily propenal derivatives 17b-d were unstable and polymerized slowly at room temperature. However, the crystalline propenal 17a could be kept for long periods without deterioration.
25. a) Parikh J. R., von Doering W. E., J. Am. Chem. Soc., 89, 5505-5507 (1967);
26. b) Hamada Y., Shioiri T., Chem. Pharm. Bull., 30, 1921-1924 (1982).
27. a) Omura K., Sharma A. K., Swern D., J. Org. Chem., 41, 957-962 (1976);
28. b) Huang S. L., Omura K., Swern D., Synthesis, 1978, 297-299.
29. Mancera O., Rosenkranz G., Sondheimer F., J. Chem. Soc., 1953, 2189-2191.
30. Morie T., Kato S., Harada H., Watanabe K., Fujiwara I., Matsumoto J., J. Chem. Soc. Perkin Trans. 1, 1994, 2565-2569.
31. Seki S., Hirayama M., Onodera M., Japan Kokai 72 27953 [Chem. Abstr., 78, 15810y (1972)].
32. a) Linden G. B., Gold M. H., J. Org. Chem., 21, 1175-1176 (1956);
33. b) Poptrpwsla H., Urbanski T., Kmiotek I., Rocz. Chem., 47, 409-413 (1973);
34. c) Kupper R. J., Jachimowicz F., Quirk J. M., Hakansson C. L., U S Patent, 4851588 (1989) [Chem. Abstr., 112, 118253u (1990)].
35. Smith R. F., Kirchner F. K., J. Org. Chem., 23, 621 (1958).
36. a) Snyder H. R., Thompson C. B., Hinman R. L., J. Am. Chem. Soc., 74, 2009-2012 (1952);
37. b) Ferrari M., Ripa A., Ripa G., Sisti M., J. Heterocycl. Chem., 26, 531-532 (1989).
38. Foster A. B., Horton D., J. Chem. Soc., 1958, 1890-1894.
39. a) Juckar E., Rissi E., Helv. Chim. Acta, 45, 2383-2403 (1962);
40. b) Cortes S., Kohn H., J. Org. Chem., 48, 2246-2254 (1983).
41. a) Kraiz B. O., Shenberg N. N., Ivin B. A., Zh. Org. Khim., 21, 419-427 (1985) [Chem. Abstr., 103, 71284b (1985)];
42. a) Kraiz B. O., Shenberg N. N., Ivin B. A., Zh. Org. Khim., 21, 419-427 (1985) [Chem. Abstr., 103, 71284b (1985)];
43. b) Ouirk J. M., Harsy S. G., Hakansson C. L., Eur. Pat. Appl. EP 348223 (1989) [Chem. Abstr., 113, 6354s (1990)].
44. 1H-NMR spectrum showed slight contamination with 35 (ca. 2%). The recrystallization from iso-PrOH of the powder resulted in an increase of 35 (ca. 20%).
45. Societe d'Etudes Scientifiques et Industrielles de l'Ile-de-France Fr. M. 6817 [Chem. Abstr., 74, 130376r (1971)].